company background image
3002

Sinocare SZSE:300298 Stock Report

Last Price

CN¥27.17

Market Cap

CN¥15.1b

7D

3.6%

1Y

15.5%

Updated

04 Oct, 2022

Data

Company Financials +
300298 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance4/6
Financial Health5/6
Dividends4/6

300298 Stock Overview

Sinocare Inc. engages in the development, manufacture, and marketing of diagnosis rapid testing products primarily in the People’s Republic of China.

Sinocare Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sinocare
Historical stock prices
Current Share PriceCN¥27.17
52 Week HighCN¥33.50
52 Week LowCN¥13.30
Beta0.87
1 Month Change-1.06%
3 Month Change-5.10%
1 Year Change15.47%
3 Year Change102.01%
5 Year Change48.20%
Change since IPO332.47%

Recent News & Updates

Shareholder Returns

300298CN Medical EquipmentCN Market
7D3.6%11.7%-1.5%
1Y15.5%-23.0%-19.2%

Return vs Industry: 300298 exceeded the CN Medical Equipment industry which returned -23% over the past year.

Return vs Market: 300298 exceeded the CN Market which returned -19.2% over the past year.

Price Volatility

Is 300298's price volatile compared to industry and market?
300298 volatility
300298 Average Weekly Movement6.4%
Medical Equipment Industry Average Movement5.9%
Market Average Movement5.8%
10% most volatile stocks in CN Market9.2%
10% least volatile stocks in CN Market3.8%

Stable Share Price: 300298 is not significantly more volatile than the rest of CN stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: 300298's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20023,588Shao Bo Lihttps://www.sinocare.com

Sinocare Inc. engages in the development, manufacture, and marketing of diagnosis rapid testing products primarily in the People’s Republic of China. It offers SARS-CoV-2 antibody test strip; Safe-Accu blood glucose monitoring systems; Safe-AQ blood glucose monitoring systems; Gold-Accu blood glucose monitoring systems; Safe-Accu UG blood, glucose, and uric acid monitoring systems; Safe-Accu KG blood, glucose, and ketone monitoring systems; and D Nurse mobile glucose meters. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals.

Sinocare Inc. Fundamentals Summary

How do Sinocare's earnings and revenue compare to its market cap?
300298 fundamental statistics
Market CapCN¥15.14b
Earnings (TTM)CN¥198.49m
Revenue (TTM)CN¥2.52b

76.3x

P/E Ratio

6.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
300298 income statement (TTM)
RevenueCN¥2.52b
Cost of RevenueCN¥1.09b
Gross ProfitCN¥1.43b
Other ExpensesCN¥1.23b
EarningsCN¥198.49m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.36
Gross Margin56.63%
Net Profit Margin7.87%
Debt/Equity Ratio26.1%

How did 300298 perform over the long term?

See historical performance and comparison

Dividends

0.7%

Current Dividend Yield

56%

Payout Ratio